We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODX
3726
Co-Diagnostics
CODX
$5.49M
$34K ﹤0.01%
357
-274
-43% -$38.3K
BHIL
3727
DELISTED
Benson Hill, Inc.
BHIL
$34K ﹤0.01%
359
-57
-14% -$6.28K
INO icon
3728
Inovio Pharmaceuticals
INO
$79.1M
$33K ﹤0.01%
1,596
-785
-33% -$20.1K
TT icon
3729
CALL
Trane Technologies
TT
$106B
$33K ﹤0.01%
+32,500
New +$4.86M
EGLX
3730
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$33K ﹤0.01%
+38,481
New +$59K
ACIC icon
3731
American Coastal Insurance
ACIC
$464M
$32K ﹤0.01%
50,440
NKTR icon
3732
Nektar Therapeutics
NKTR
$2.55B
$32K ﹤0.01%
667
-372
-36% -$22.1K
UGP icon
3733
Ultrapar
UGP
$6.34B
$32K ﹤0.01%
14,506
+21
+0.1% +$53
WKHS icon
3734
Workhorse Group
WKHS
$34.1M
$32K ﹤0.01%
4
-2
-33% -$19.4K
GTE icon
3735
Gran Tierra Energy
GTE
$337M
$31K ﹤0.01%
2,536
+1,500
+145% +$18.7K
HWM icon
3736
CALL
Howmet Aerospace
HWM
$112B
$31K ﹤0.01%
10,300
JPM icon
3737
CALL
JPMorgan Chase
JPM
$962B
$31K ﹤0.01%
103,600
+20,200
+24% +$2.32M
STEM icon
3738
CALL
Stem
STEM
$52.8M
$31K ﹤0.01%
920
-2,570
-74% -$657K
PDYN icon
3739
Palladyne AI
PDYN
$312M
$30K ﹤0.01%
2,250
FTH
3740
Faeth Therapeutics
FTH
$773M
$29K ﹤0.01%
950
DHC
3741
Diversified Healthcare Trust
DHC
$1.98B
$28K ﹤0.01%
28,717
+1,450
+5% +$2.32K
HUYA
3742
Huya Inc
HUYA
$556M
$28K ﹤0.01%
12,790
-210
-2% -$678
MRK icon
3743
CALL
Merck
MRK
$322B
$28K ﹤0.01%
34,700
-35,300
-50% -$3.15M
MSC
3744
Studio City International Holdings
MSC
$327M
$28K ﹤0.01%
12,986
VXRT
3745
DELISTED
Vaxart
VXRT
$28K ﹤0.01%
12,893
-288
-2% -$993
AXDX
3746
DELISTED
Accelerate Diagnostics
AXDX
$27K ﹤0.01%
+1,750
New +$29K
QTTB icon
3747
Q32 Bio
QTTB
$459M
$27K ﹤0.01%
937
APTX
3748
DELISTED
Aptinyx Inc. Common Stock
APTX
$27K ﹤0.01%
74,025
COMP icon
3749
Compass
COMP
$9.74B
$26K ﹤0.01%
11,400
-348,432
-97% -$1.24M
EVLV icon
3750
Evolv Technologies
EVLV
$1.08B
$26K ﹤0.01%
+12,200
New +$31.8K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.